Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins

/PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a drug discovery...

Related Keywords

United States ,Osaka ,Japan ,Texas ,North Carolina ,Japanese ,Taylor Schreiber ,Toichi Takino ,Gyo Sagara ,Nasdaq ,Discovery Research Of Ono ,Prnewswire Ono Pharmaceutical Co Ltd ,Shattuck Labs Inc ,Shattuck Labs ,Senior Executive Officer ,Executive Director ,Ono Pharmaceutical ,Chief Executive Officer ,Agonist Redirected Checkpoint ,Ono Pharmaceutical Co ,Td ,